| Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ... Cell 183 (3), 818-834. e13, 2020 | 422 | 2020 |
| Replication of associations between genetic polymorphisms and chronic graft-versus-host disease Blood 128 (20), 2450-2456, 2016 | 410* | 2016 |
| IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data D Wang, L Yan, Q Hu, LE Sucheston, MJ Higgins, CB Ambrosone, ... Bioinformatics 28 (5), 729-730, 2012 | 347 | 2012 |
| Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis JD Waight, C Netherby, ML Hensen, A Miller, Q Hu, S Liu, PN Bogner, ... The Journal of clinical investigation 123 (10), 4464-4478, 2013 | 346 | 2013 |
| Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism JD Waight, Q Hu, A Miller, S Liu, SI Abrams PloS one 6 (11), e27690, 2011 | 282 | 2011 |
| Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators L Wei, J Wang, E Lampert, S Schlanger, AD DePriest, Q Hu, EC Gomez, ... European urology 71 (2), 183-192, 2017 | 241 | 2017 |
| MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer Y Yasumizu, H Rajabi, C Jin, T Hata, S Pitroda, MD Long, M Hagiwara, ... Nature communications 11 (1), 338, 2020 | 135 | 2020 |
| Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer D Zhang, Q Hu, X Liu, Y Ji, HP Chao, Y Liu, A Tracz, J Kirk, S Buonamici, ... Nature communications 11 (1), 2089, 2020 | 120 | 2020 |
| Circulating miR-148b and miR-133a as biomarkers for breast cancer detection J Shen, Q Hu, M Schrauder, L Yan, D Wang, L Medico, Y Guo, S Yao, ... Oncotarget 5 (14), 5284, 2014 | 98 | 2014 |
| IonStar enables high-precision, low-missing-data proteomics quantification in large biological cohorts X Shen, S Shen, J Li, Q Hu, L Nie, C Tu, X Wang, DJ Poulsen, BC Orsburn, ... Proceedings of the National Academy of Sciences 115 (21), E4767-E4776, 2018 | 88 | 2018 |
| Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer S Ramakrishnan, V Granger, M Rak, Q Hu, K Attwood, L Aquila, ... Cell Death & Differentiation 26 (10), 2100-2114, 2019 | 82 | 2019 |
| Low 25 (OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia HJ Lee, JR Muindi, W Tan, Q Hu, D Wang, S Liu, GE Wilding, LA Ford, ... Cancer 120 (4), 521-529, 2014 | 82 | 2014 |
| Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer S Liu, J Matsuzaki, L Wei, T Tsuji, S Battaglia, Q Hu, E Cortes, L Wong, ... Journal for immunotherapy of cancer 7, 1-17, 2019 | 81 | 2019 |
| An IonStar experimental strategy for MS1 ion current-based quantification using ultrahigh-field orbitrap: reproducible, in-depth, and accurate protein measurement in large cohorts X Shen, S Shen, J Li, Q Hu, L Nie, C Tu, X Wang, B Orsburn, J Wang, J Qu Journal of proteome research 16 (7), 2445-2456, 2017 | 79 | 2017 |
| Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients C Tu, MJ Mammen, J Li, X Shen, X Jiang, Q Hu, J Wang, S Sethi, J Qu Journal of proteome research 13 (2), 627-639, 2014 | 77 | 2014 |
| A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ... Elife 6, e28482, 2017 | 74 | 2017 |
| Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer JS Kirk, K Schaarschuch, Z Dalimov, E Lasorsa, SY Ku, S Ramakrishnan, ... Oncotarget 6 (5), 3136, 2014 | 70 | 2014 |
| KLF9 is a novel transcriptional regulator of bortezomib-and LBH589-induced apoptosis in multiple myeloma cells S Mannava, DZ Zhuang, JR Nair, R Bansal, JA Wawrzyniak, SN Zucker, ... Blood, The Journal of the American Society of Hematology 119 (6), 1450-1458, 2012 | 70 | 2012 |
| Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers JW Phillips, Y Pan, BL Tsai, Z Xie, L Demirdjian, W Xiao, HT Yang, ... Proceedings of the National Academy of Sciences 117 (10), 5269-5279, 2020 | 68 | 2020 |
| Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients PK Singh, L Preus, Q Hu, L Yan, MD Long, CD Morrison, M Nesline, ... Oncotarget 5 (3), 824, 2014 | 68 | 2014 |
